Fidelity Wise Origin Bitcoin Fund FBTC Assessing Investment Viability Amid Crypto ETF Rally and Regulatory Uncertainties ELUT Elutia delivers blowout Q4 2025 EPS results yet shares fall 183 in postearnings trading Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia